Agenda.

08.30 Opening Remarks

Opening Remarks: Prof John McCaffrey, The Mater Misericordiae University Hospital, Dublin & Prof David Gallagher, St James’s Hospital, Dublin

08.35 Welcome Address

Welcome Address: Prof Michaela Higgins, Irish Society of Medical Oncology President

Chairs: Prof John McCaffrey, The Mater Misericordiae University Hospital, Dublin & Prof David Gallagher, St James’s Hospital, Dublin

08.45
Identifying Mechanisms of Resistance Arising from Cyclin-Dependent Kinase 4/6 Inhibitor Exposure That Impact on Breast Cancer Brain Metastases Progression Free Survival
Dr Sonya Chew, MSKCC, New York

09.00
Circulating Tumour DNA in Gastrointestinal Cancers
Dr Darren Cowzer, MSKCC, New York

09.15
Circulating Tumour DNA in NSCLC: Right Test, Right Time
Dr Hazel O’Sullivan, The Royal Marsden NHS Foundation Trust, London

09.30
All Kinds of Everything
Dr Niamh Peters, The Christie NHS Foundation Trust, Manchester

Chairs: Dr Helen Greally, Cancer Care West & Ms Sandra Flynn, Mater Misericordiae University Hospital, Dublin

09.45
The Role of ANP in Establishing Gynaecology Oncology Family History Service
Sarah Belton, St Vincent’s University Hospital, Dublin

10.05
Women’s Health Initiative & Embedding Patients & Carers’ Insights into their own Management
Ms Yvonne O’Meara, University College Dublin

10.25
Menopause after Cancer Care
Dr Fionan Donohue, The Living Well Cancer Programme

10.45
Mainstreaming Germline Genetic Testing for All Cancer Patients
Prof Heather Hampel, City of Hope Medical Center, California

11.05-11.30 Coffee Break

Chairs: Ms Catherine O’Brien, St James’s Hospital, Dublin & Dr Eileen Furlong, UCD School of Nursing

11.30
ANP Role in Community Oncology
Ms Caroline Smyth, Health Service Executive, Ireland

11.45
"Translation of Research into Clinical Practice" - RANP Perspective
Ms Liz Summersby, Our Lady of Lourdes Hospital, Drogheda

12.00
ANP Lung Cancer Surveillance
Ms Rosemarie Murphy, University Hospital Limerick

12.15
The Oncology Nurse Practitioner Role in Advancing Patient Care
Ms Liz Meade, Midland Regional Hospital Tullamore

12.30
ANP Led Acute Oncology Service, An Irish Perspective
Ms Margaret Allen, Cork University Hospital

12.45
ANP Role in Non-Muscle Invasive Bladder Cancer
Mr Robert McConkey, Galway University Hospital

13.00
Development & Pilot of an Integrated Care Model for the Management of Patients Receiving Oral Anti-Cancer Medication by an ANP
Dr Janice Richmond, Letterkenny University Hospital, Donegal

13.30 - 14.30 Lunch

Chairs: Dr Geraldine O’Sullivan Coyne, National Cancer Institute, Bethesda & Prof Donal Brennan, Mater Misericordiae University Hospital, Dublin

14.30
Cervical Cancer Update
Dr Roisin O’Cearbhaill, MSKCC, New York

14.50
Endometrial Cancer Update
Dr Roshni Kalachand, Beaumont Hospital, Dublin

15.10
Ovarian Cancer Update
Dr Karen Cadoo, St James’s Hospital, Dublin

15.30 - 15.50 Coffee Break

Chairs: Prof Patrick Morris, Beaumont Hospital, Dublin & Dr Michael McCarthy, Galway University Hospital

15.50
Phase 1 Trials – A Historical Update
Dr Alice Chen, National Cancer Institute, Bethesda

16.10
Modern Phase 1 Trial Design
Dr Geraldine O’Sullivan Coyne, National Cancer Institute, Bethesda

16:30
START: Prof Austin Duffy, Mater Misericordiae University Hospital, Dublin

16.50
Cancer Trials Ireland: Ambitions for the Next Decade
Prof Seamus O’Reilly, Cork University Hospital

17.10
Chair of OECI Accreditation and Designation
Dr Jean-Benoit Burrion, Organisation of European Cancer Institutes

17.30 End of Day 1